Immunic | VTL - Interest Expense On Debt


Immunic reported 197K in Interest Expense on Debt for its fiscal quarter ending in December of 2025.





Interest Expense On Debt Change Date
BioMarin Pharmaceutical USD 14.96M 12.18M Mar/2026
Cipla INR 131.3M 9M Mar/2026
Compugen USD 1.35M 399K Mar/2026
CSL USD 215M 111M Dec/2025
Enanta Pharmaceuticals USD 1.96M 620K Dec/2024
Grifols EUR 156.07M 31.46M Sep/2025
Immunic 197K 222K Dec/2025
Insmed USD 20.08M 517K Mar/2026
Omeros USD 4.05M 5.16M Sep/2024
OraSure Technologies 1.67M 1.13M Dec/2025
Quidel USD 5.63B 5.58B Mar/2026
Ultragenyx Pharmaceutical USD 21M 2M Mar/2026
United Therapeutics USD 3.1M 100K Dec/2025
Xoma USD 3.4M 150K Jun/2024